LifeStance Health Group Inc [LFST] stock is trading at $5.08, up 2.63%. An important factor to consider is whether the stock is rising or falling in short-term value. The LFST shares have gain 3.04% over the last week, with a monthly amount drifted -16.17%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
LifeStance Health Group Inc [NASDAQ: LFST] stock has seen the most recent analyst activity on May 27, 2025, when UBS upgraded its rating to a Buy but kept the price target unchanged to $8.50 for it. Previously, KeyBanc Capital Markets started tracking the stock with Overweight rating on April 08, 2025, and set its price target to $9. On April 03, 2025, Canaccord Genuity initiated with a Buy rating and assigned a price target of $8 on the stock. Goldman upgraded its rating to a Buy but stick to its price target of $10 on December 16, 2024. Barclays initiated its recommendation with a Underweight and recommended $7 as its price target on January 03, 2024. TD Cowen downgraded its rating to Market Perform for this stock on May 15, 2023, and upped its price target to $9. In a note dated January 06, 2023, Morgan Stanley upgraded an Overweight rating on this stock but restated the target price of $8.
LifeStance Health Group Inc [LFST] stock has fluctuated between $4.64 and $8.61 over the past year. Currently, Wall Street analysts expect the stock to reach $8.5 within the next 12 months. LifeStance Health Group Inc [NASDAQ: LFST] shares were valued at $5.08 at the most recent close of the market. An investor can expect a potential return of 67.32% based on the average LFST price forecast.
Analyzing the LFST fundamentals
LifeStance Health Group Inc [NASDAQ:LFST] reported sales of 1.28B for the trailing twelve months, which represents a growth of 10.83%. Gross Profit Margin for this corporation currently stands at 0.3% with Operating Profit Margin at -0.01%, Pretax Profit Margin comes in at -0.03%, and Net Profit Margin reading is -0.03%. To continue investigating profitability, this company’s Return on Assets is posted at -0.02, Equity is -0.02 and Total Capital is -0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.13.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.98 points at the first support level, and at 4.88 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.14, and for the 2nd resistance point, it is at 5.20.
Ratios To Look Out For
For context, LifeStance Health Group Inc’s Current Ratio is 1.47. On the other hand, the Quick Ratio is 1.47, and the Cash Ratio is 0.65. Considering the valuation of this stock, the price to sales ratio is 1.54, the price to book ratio is 1.36.
Transactions by insiders
Recent insider trading involved Ramtekkar Ujjwal, Chief Medical Officer, that happened on Jun 16 ’25 when 9519.0 shares were sold. Officer, Ramtekkar Ujjwal completed a deal on Jun 16 ’25 to buy 9519.0 shares. Meanwhile, Chief Medical Officer Ramtekkar Ujjwal sold 16000.0 shares on Jun 05 ’25.
